A Study of MRG003 in Patients With Advanced Solid Tumors

NCT04868344 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Miracogen Inc.